2020 On-site

What 2020 On-site does

20/20 Onsite is a privately held Boston-based healthcare services company that provides point-of-need ophthalmic assessments for clinical trials sponsored by pharmaceutical and biotechnology companies, as well as contract research organizations. Founded in 2014 by Howard Bornstein as a corporate wellness eye-care provider, the company pivoted to clinical research during the COVID-19 pandemic in 2020 after a major pharmaceutical sponsor engaged it to rescue a disrupted trial. Since the pivot, the company has supported 45+ clinical trials across 48 states and performed more than 100,000 point-of-need eye exams.

The company's core offering rests on three physical delivery modalities: Mobile Vision Clinics (fully equipped vehicles), Mobile Vision Pods (semi-permanent modular spaces), and Mobile Clinical Suites (portable equipment and staff for existing facilities). All units use calibrated, validated equipment compliant with 21 CFR Part 11, GCP, HIPAA, and GDPR standards, and clinical staff average 11+ years of ophthalmic experience. The service portfolio spans study design and protocol consultation, patient prescreening and enrollment, exam integration at existing sites, patient retention, trial rescue, and post-marketing surveillance, with each engagement generating custom contract pricing based on scope, geography, and duration. The company maintains both a clinical trial solutions business and a smaller corporate/community vision-care program (the Vision for Boston initiative has served over 5,000 children since 2015).

Revenue is generated through negotiated multi-year professional services contracts with pharmaceutical sponsors and CROs, supplemented by corporate wellness engagements. Sales are driven by enterprise field sales to clinical operations leaders at sponsors and CROs, supported by thought-leadership content (the 'Eyes on Research' blog, webinars, case studies), industry conference participation, and earned media. The company has raised approximately $23.8 million in disclosed funding across rounds from 2014 through 2021, with an $8 million growth financing closing in May 2021.

Name

2020 On-site

Legal name

20/20 Onsite

Website

https://2020onsite.com

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

11–50 employees

Short description

20/20 Onsite is a private Boston-based healthcare services company that delivers point-of-need ophthalmic assessments for pharmaceutical and biotech clinical trials via a nationwide fleet of Mobile Vision Clinics, Pods, and Clinical Suites, serving trial sponsors, CROs, and select corporate clients.

Ownership category

akta.pro rank

Product category

Clinical Trial Ophthalmic Assessment Services

NAICS

Offices of Physicians (6211), Diagnostic Imaging Centers (621512)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Ocular Imaging & Diagnostic Testing Centers (HLAKAKAN)

Keywords

• Mobile ophthalmic assessments
• Clinical trial solutions
• Point-of-need vision care
• Ocular endpoint protection
• Decentralized clinical trials

Headquarters

HQ city

Boston

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

1. Clinical Trial Ophthalmic Assessment Services: 20/20 Onsite provides point-of-need ophthalmic assessments for clinical trial sponsors and CROs. Revenue is generated through service contracts for Phase 1-4 clinical trials, covering protocol consultation, prescreening, enrollment support, endpoint assessments, and post-marketing surveillance. Pricing varies based on trial scope, number of assessments, geographic coverage, and duration.

Pricing tiers

Go-to-market motion2 records

Distribution channels1 record

Marketing channels6 records

Core offering

20/20 Onsite delivers point-of-need ophthalmic assessment services for clinical trials through three mobile delivery modalities: fully-equipped Mobile Vision Clinics (MVCs), semi-permanent Mobile Vision Pods (MVPs), and Mobile Clinic Suites (MCSs) deployed at existing facilities. The company provides certified ophthalmic assessments (OCT, BCVA, slit lamp, fundus photography, visual field, etc.) along with protocol consultation, prescreening, enrollment support, endpoint assessments, and post-marketing surveillance for Phase 1-4 trials. Services are contracted directly with pharmaceutical sponsors and CROs, executing ocular assessments at trial participant locations across 48 states.

Product overview

20/20 Onsite is a specialized healthcare services company providing point-of-need ophthalmic clinical trial solutions through three innovative delivery modalities: Mobile Vision Clinics (MVCs), Mobile Vision Pods (MVPs), and Mobile Clinic Suites (MCSs). The company offers a comprehensive portfolio of services including study design and protocol review, patient prescreening and enrollment, seamless exam integration, patient retention programs, and post-marketing surveillance. Their core offering centers on bringing certified ophthalmic assessments directly to trial participants wherever they are located, eliminating geographical barriers and reducing patient burden. The platform supports Phase 1-4 clinical trials and addresses various therapeutic areas including CNS, ophthalmic, respiratory, and rare diseases. Key assessment capabilities include OCT, fundus photography, visual acuity testing, slit lamp biomicroscopy, and intraocular pressure measurements, all performed by certified clinical professionals with an average of 11+ years of ophthalmic experience.

Differentiator

Problem solved

Functional benefit

Products and services

• Mobile Vision Clinic (MVC) Fully-equipped clinics on wheels providing comprehensive ophthalmic assessments for clinical trial participants at their homes, workplaces, or other convenient locations. Specially-equipped, fully-staffed vehicles have traveled over 200,000 miles across 48 states.
• Mobile Vision Pod (MVP) Semi-permanent, modular examination spaces that can be set up and customized per study requirements, offering a cost-effective solution for on-site ophthalmic assessments at clinical trial locations.
• Mobile Clinic Suite (MCS) Portable solutions bringing ophthalmic equipment and certified staff to existing exam rooms and suitable facilities, seamlessly integrating with clinic workflows for point-of-need assessments.
• Clinical Trial Solutions for Phase 1-3 End-to-end mobile ophthalmic solutions supporting every phase of clinical trials from protocol consultation and precision prescreening to enrollment acceleration and patient retention.
• Post Marketing & Real World Evidence Solutions

Quantifiable outcome

• Patient dropout rates reduced by 70% compared to industry average (achieving 9% vs 30% industry standard)
• +5 more outcomes

Named customers10 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Nine partnerships are on record, tiered minor and core.

• American Diabetes AssociationminorGTM or Marketing Partner · 19 September 2025Partnership for ADA Step Out: Walk to Stop Diabetes events, with 20/20 Onsite mobile vision clinic conducting free eye screenings to promote diabetes-related eye health awareness.
• Sano GeneticsminorStrategic or Co-development Partner · 16 October 2024Partnership to boost access to specialist eye care and related research for US patients, combining genetic testing capabilities with ophthalmic assessment services.
• MyzeminorStrategic or Co-development Partner · 21 June 2023Partnership to change daily eye care for over 65,000 patients through integrated mobile vision clinic and daily eye care platform services.
• The Vision Council FoundationminorStrategic or Co-development Partner · 20 March 2023Partnership to provide vision screenings at Boston Public Library locations, expanding access to eye care for underserved populations in partnership with The Vision Council Foundation.
• Warby ParkerminorStrategic or Co-development Partner · 11 January 2023Partnership supporting Vision for Boston program, with Warby Parker providing eyewear for underprivileged students receiving eye exams through the mobile clinic program.
• Greater GiftminorGTM or Marketing Partner · 24 August 2021Partnership to honor and celebrate clinical trial participants while providing eye exams to underserved children in the local community through coordinated Giving Back initiatives.
• Syneos HealthcoreStrategic or Co-development Partner · 17 June 2020Syneos Health, a leading fully integrated biopharmaceutical solutions organization, partnered with 20/20 Onsite to deploy Mobile Vision Clinics and Mobile Clinical Suites for Phase 1 clinical trial support. The partnership enabled ocular safety assessments at research sites lacking specialized equipment and personnel, with 65+ patients successfully enrolled across multiple studies.
• AGTC (Applied Genetic Technologies Corporation)coreStrategic or Co-development Partner · 15 June 2020AGTC launched a nationwide mobile vision testing program with 20/20 Onsite for patients enrolled in ongoing Phase 1/2 clinical trials for X-linked Retinitis Pigmentosa and Achromatopsia gene therapy treatments. The partnership enabled patient participation during COVID-19 travel restrictions.
• Boston Public SchoolscoreStrategic or Co-development Partner · 1 January 2015Long-running 'Vision for Boston' program providing free vision screenings, eye exams, and eyewear to over 5,000 underprivileged children. Funded through corporate office visit revenue, creating sustainable philanthropy model.

Scale indicators12 records

Recent moves9 records

Expansion highlights4 records

Emerging players

• Medable: Decentralized clinical trial technology provider; overlaps on the shift toward point-of-need trial execution but does not specialize in ophthalmic assessments.
• Science 37: Decentralized clinical trial platform enabling remote assessments; overlaps with 20/20 Onsite's mobile deployment thesis but covers multiple therapeutic endpoints, not specialized in ophthalmology.

Direct peers

• Clario: Clinical trial imaging and endpoint services provider with ophthalmic imaging capabilities, directly competing in the same specialized ophthalmic endpoint execution space as 20/20 Onsite.
• EyeCRO: Specialty ophthalmic clinical research organization providing ophthalmic clinical trial services, overlapping directly with 20/20 Onsite's specialty CRO positioning for ocular endpoints.
• ORA Clinical Research: Specialty ophthalmic clinical research organization offering site and ophthalmic assessment services for trials, directly comparable to 20/20 Onsite's focus on ocular endpoints.

Broad incumbents

• Syneos Health: Large full-service CRO and 20/20 Onsite's named partner for Phase 1 ocular safety work; broader portfolio across clinical development but overlapping on ophthalmic trial execution.
• Worldwide Clinical Trials: Mid-size global CRO with strong CNS and metabolic therapeutic area presence; competes for the same pharma sponsors running trials with ocular safety endpoints.
• Medpace: Mid-to-large CRO with therapeutic-area depth including CNS and ophthalmology, overlapping on trials where ocular endpoints are required.
• ICON plc: Major global CRO with ophthalmic and CNS trial experience; broader service portfolio but overlapping on trials requiring ocular endpoint assessments.
• IQVIA: Largest global CRO with broad ophthalmic trial capabilities; competes for the same pharma sponsor budgets as 20/20 Onsite but lacks its point-of-need mobile specialization.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/2020onsite
• Facebookfacebook.com/2020onsite
• LinkedInlinkedin.com/company/2020onsite
• Instagraminstagram.com/2020onsite

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles13 records

Funding overview

Funding rounds5 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about 2020 On-site